These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32868525)

  • 1. Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial).
    Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsui S; Teramukai S; Murotani K; Ajioka Y; Shimazaki H; Maeda A; Takuma K; Yoshida T; Kambara T; Matsuda K; Takagane A; Tomita N; Sugihara K;
    Am J Surg Pathol; 2020 Dec; 44(12):1685-1698. PubMed ID: 32868525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
    Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsuda C; Nakamoto Y; Kotake M; Kurachi K; Egawa T; Yasumasa K; Murata K; Ikawa O; Shinji S; Murotani K; Matsui S; Teramukai S; Tomita N; Sugihara K;
    J Clin Oncol; 2019 Aug; 37(22):1886-1894. PubMed ID: 31180819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.
    Konishi T; Shimada Y; Lee LH; Cavalcanti MS; Hsu M; Smith JJ; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Vakiani E; Gonen M; Shia J; Weiser MR
    Am J Surg Pathol; 2018 Jun; 42(6):705-714. PubMed ID: 29624511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
    Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
    J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
    Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
    Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer.
    Yoshino T; Kotaka M; Shinozaki K; Touyama T; Manaka D; Matsui T; Ishigure K; Hasegawa J; Inoue K; Munemoto Y; Takagane A; Ishikawa H; Ishida H; Ogata Y; Oba K; Goto K; Sakamoto J; Maehara Y; Ohtsu A
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1269-1277. PubMed ID: 31549217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features?
    Cavallaro PM; Stafford C; Cauley CE; Berger DL; Bordeianou L; Kunitake H; Francone T; Ricciardi R
    Dis Colon Rectum; 2021 May; 64(5):545-554. PubMed ID: 33939386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients.
    Oki E; Shinto E; Shimokawa M; Yamaguchi S; Ishiguro M; Hasegawa S; Takii Y; Ishida H; Kusumoto T; Morita M; Tomita N; Shiozawa M; Tanaka M; Ozawa H; Hashiguchi Y; Ohnuma S; Tada S; Matsushima T; Hase K
    BMC Cancer; 2021 Dec; 21(1):1332. PubMed ID: 34906120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters.
    Ueno H; Hase K; Hashiguchi Y; Shimazaki H; Tanaka M; Miyake O; Masaki T; Shimada Y; Kinugasa Y; Mori Y; Kishimoto M; Kameoka S; Sato Y; Matsuda K; Nakadoi K; Shinto E; Nakamura T; Sugihara K
    Am J Surg Pathol; 2014 Feb; 38(2):197-204. PubMed ID: 24418853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between poorly differentiated clusters and efficacy of 5-fluorouracil-based adjuvant chemotherapy in stage III colorectal cancer.
    Tajima Y; Shimada Y; Kameyama H; Yagi R; Okamura T; Kobayashi T; Kosugi SI; Wakai T
    Jpn J Clin Oncol; 2017 Apr; 47(4):313-320. PubMed ID: 28100684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
    Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
    Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial.
    Protic M; Stojadinovic A; Nissan A; Wainberg Z; Steele SR; Chen DC; Avital I; Bilchik AJ
    J Am Coll Surg; 2015 Sep; 221(3):643-51; quiz 783-5. PubMed ID: 26213360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
    Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
    Lee VWK; Chan KF
    Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
    Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
    Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings.
    Tashiro J; Yamaguchi S; Ishii T; Suzuki A; Kondo H; Morita Y; Hara K; Koyama I
    World J Surg Oncol; 2014 May; 12():145. PubMed ID: 24884880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study.
    van den Berg I; van de Weerd S; Roodhart JML; Vink GR; van den Braak RRJC; Jimenez CR; Elias SG; van Vliet D; Koelink M; Hong E; van Grevenstein WMU; van Oijen MGH; Beets-Tan RGH; van Krieken JHJM; IJzermans JNM; Medema JP; Koopman M;
    BMC Cancer; 2020 Aug; 20(1):776. PubMed ID: 32811457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive significance of MSI in stages II/III colon cancer.
    Saridaki Z; Souglakos J; Georgoulias V
    World J Gastroenterol; 2014 Jun; 20(22):6809-14. PubMed ID: 24944470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.